Runner's Web
Runner's and Triathlete's Web News
Send To A friend Know someone else who's interested in running and triathlon?
Send this Runner's Web Story's URL to a friend.   Comment on this story.
Visit the FrontPage for the latest news.   |     View in Runner's Web Frame

This article about running is a good example of the advice that can be found every month in Peak Performance. The Peak Performance newsletter keeps you informed of the latest techniques and breakthroughs in training research – and how to use these in your own sports-specific fitness program.
Subscribe to Peak performance Online below:

Posted: June 23, 2005

Science of Sport: Runner’s high - a new explanation

How To Win:
Free regular
world-class
triathlon training tips.
Enter email here:


The state of euphoria induced by prolonged exercise was known first as ‘second wind’ and more recently as ‘runner’s high’. Scientists originally attempted to explain the experience in terms of the effects of the ‘stress hormones’ adrenaline and noradrenaline. Then came the ‘endorphin hypothesis’. And now we have the ‘endocannabinoid hypothesis’: a suggestion that the physical and psychological wellbeing experienced by many endurance athletes is due to the exercise-induced activation of endogenous cannabinoids – lipids whose actions in the body resemble those of the active constitutent of cannabis.

This theory, supported by scientific evidence that exercise boosts blood concentrations of endocannabinoids, is given a thorough airing in a review by US researchers published in the British Journal of Sports Medicine.

Their first point is that the endorphin hypothesis – that the runner’s high is induced by the release of endogenous opioids in response to exercise – doesn’t hold water because, among other lesser reasons, these chemicals are simply too large to cross the blood-brain barrier and exert the central effects that are claimed for them.

The endocannabinoid hypothesis, on the other hand, is supported by the following observations:

  • Unlike opioids, endocannabinoids can suppress pain at peripheral sites as well as centrally;
  • Unlike opioids, they do not produce such side effects as severe respiratory depression, pinpoint pupils and constipation;
  • Endocannabinoids inhibit swelling and inflammation and reduce pain caused by the release of chemicals (such as lactic acid);
  • The intense psychological experiences reported by users of cannabis – sedation, reduced anxiety, distortions of time estimation, euphoria, enhanced sensory perception and feelings of wellbeing – are strikingly similar to the experience of runner’s high;
  • Research on animals has suggested that one of the principal roles of the endocannabinoid system may be the refinement of movements needed for coordinated locomotion;
  • Activation of endogenous cannabinoids through exercise could account for the phenomenon of exercise addiction;
  • Endocannabinoids act as vasodilators and bronchodilators, which should make exercise feel easier.

As the authors of the review point out: ‘Further research is necessary to characterise the precise nature of this endocannabinoid response to exercise, specifically the relative importance of factors such as the nature of the activity, exercise duration, exercise intensity, sex and age.’

But in the meantime they suggest that the endocannabinoid hypothesis is a feasible alternative to the endorphin theory and should be investigated as such.

Br J Sports Med 2004;38:536-541

How To Win: free regular running training tips.
Enter email here:

Total Immersion

If you would like to comment on this article, please visit the Runner's Web Message Board.
Check out our FrontPage for all the latest running and triathlon news.

Top of News
Runner's Web FrontPage
  Google Search for:   in   Web Site       Translate